Novo Holdings A/S
Novo Holdings A/S's open-market purchases and sales year by year since 2006, and every transaction reported to the SEC on Form 4: date, shares, price and a…
Insider buying and selling since 2014
Novo Holdings A/S bought shares on the open market in 11 different years since 2014 across 18 companies. Sales in 8 of the 13 years since 2014.
Novo Holdings A/S reported 22 open-market purchases and 28 sales since 2014; purchases in 11 different years, most recently 2025.
| Year | Bought | Sold |
|---|---|---|
| 2025 | 1×1 trade | — |
| 2024 | 2×2 trades | 5×5 trades |
| 2023 | 1×1 trade | 2×2 trades |
| 2022 | 1×1 trade | 1×1 trade |
| 2021 | 3×3 trades | 3×3 trades |
| 2020 | 5×5 trades | 2×2 trades |
| 2019 | 2×2 trades | 4×4 trades |
| 2018 | 1×1 trade | — |
| 2017 | 2×2 trades | 9×9 trades |
| 2016 | 3×3 trades | — |
| 2014 | 1×1 trade | 2×2 trades |
Insider at 18 companies
- Maplight Therapeutics MPLT2025 · 1 purchase, 0 sales
- Spruce Biosciences SPRB2020–2024 · 2 purchases, 6 sales
- Metagenomi Therapeutics MGX2024 · 2 purchases, 0 sales
- Onkure Therapeutics OKUR2021–2023 · 1 purchase, 1 sale
- Disc Medicine IRON2023 · 0 purchases, 1 sale
- Bolt Biotherapeutics BOLT2021–2022 · 1 purchase, 1 sale
- Edgewise Therapeutics EWTX2021–2022 · 2 purchases, 0 sales
- Inogen INGN2014–2021 · 0 purchases, 4 sales
- Corvus Pharmaceuticals CRVS2016–2020 · 4 purchases, 5 sales
- Harmony Biosciences Holdings, Inc. HRMY2020 · 1 purchase, 0 sales
- Damora Therapeutics DMRA2020 · 1 purchase, 0 sales
- Aligos Therapeutics ALGS2020 · 1 purchase, 0 sales
- Nkarta NKTX2020 · 1 purchase, 0 sales
- Milestone Pharmaceuticals MIST2019 · 1 purchase, 1 sale
- Mirum Pharmaceuticals MIRM2019 · 1 purchase, 0 sales
- Anaptysbio ANAB2017 · 1 purchase, 9 sales
- Irhythm Holdings IRTC2016 · 1 purchase, 0 sales
- Akebia Therapeutics AKBA2014 · 1 purchase, 0 sales
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Novo Holdings A/S's trades
Has Novo Holdings A/S bought shares on the open market?
Novo Holdings A/S bought shares on the open market in 11 different years since 2014 across 18 companies. Sales in 8 of the 13 years since 2014.
When did Novo Holdings A/S last buy or sell shares?
In SEC filings since 2014: the latest open-market purchase is from 2025; the latest open-market sale is from 2024.
Which companies has Novo Holdings A/S traded as an insider?
18 companies: Maplight Therapeutics (MPLT, 2025), Spruce Biosciences (SPRB, 2020–2024), Metagenomi Therapeutics (MGX, 2024), Onkure Therapeutics (OKUR, 2021–2023), Disc Medicine (IRON, 2023) and others.